Find IP Sell IP AI Assistant Chip Talk Chip Videos About Us
Log In

Tempus Inc.

Tempus Inc. is a cutting-edge company at the forefront of precision medicine, leveraging artificial intelligence to revolutionize the medical field. Their expertise spans oncology, neurology, and cardiology, offering innovative solutions that empower healthcare providers with actionable insights. By integrating genomic profiling with advanced EHR systems, Tempus aims to enhance patient care through a tailored approach, individualized to each patient's unique genetic and clinical data. Their data-driven methodologies provide unparalleled support in both diagnosing and treating various conditions, ensuring treatments are not only effective but also specifically suited to patient profiles.\n\nThrough extensive collaborations with pharmaceutical and biotechnology companies, Tempus facilitates more efficient drug development. Their capabilities include sequencing, AI-driven analysis, and comprehensive clinical trial support, helping streamline the drug pipeline from research to market. The company collaborates with academic and research centers to ensure their genomic and diagnostic capabilities are at the bleeding edge of science. This emphasis on integration and cooperation across the medical field positions Tempus as a leader in optimizing and enhancing therapeutic outcomes through personalized medicine.\n\nTempus is also committed to improving research and development initiatives within the life sciences sector. They provide real-world data solutions and companion diagnostics to assess and validate biomarkers, accelerating the identification of novel therapeutic targets. This approach not only speeds up drug development but also ensures that treatments are more precisely aligned with patient needs. By supporting their tools with robust datasets and AI algorithms, Tempus continues to push the boundaries of what is possible in precision medicine, making significant strides towards a future where treatments are as unique as the individuals receiving them.\n\nIn addition to diagnostics and research, Tempus offers a comprehensive platform that integrates seamlessly with existing healthcare infrastructures. Their solutions focus on identifying care gaps and supporting clinical decision-making through AI-enhanced pathways. By connecting healthcare providers with essential data and tools, Tempus ensures that the entire care continuum benefits from their precision medicine innovations, ultimately driving forward improvements in patient health and treatment efficacy. Read more

Is this your business? Claim it to manage your IP and profile

2
IPs available

xT CDx

The xT CDx is a state-of-the-art Next Generation Sequencing (NGS) diagnostic tool designed to detect genetic alterations in cancer patients. Utilizing a sample from formalin-fixed paraffin-embedded (FFPE) tissue and matched normal samples, it profiles DNA mutations across 648 genes. This comprehensive profile aids in determining personalized treatment paths and identifies patients eligible for specific therapies as detailed in therapeutic product labeling. The xT CDx not only serves as a companion diagnostic but also provides detailed tumor mutation insights crucial for treatment planning.\n\nOne of the key benefits of the xT CDx is its capability to deliver precision in diagnosis and treatment, leveraging genetic data to engage the most suitable therapies for cancer patients. The ability to identify microsatellite instability and pursue thorough tumor mutation profiling sets a new standard in personalized oncology approaches, ensuring that therapies are tailored down to the genetic level. The technology integrates seamlessly with clinical guidelines, enabling healthcare professionals to make informed, data-driven treatments.\n\nIn the landscape of companion diagnostics, the xT CDx stands out, providing wide-ranging genetic information that surpasses conventional diagnostics. Its application ensures that oncologists have access to the most relevant genetic insights, shaping a more predictive and personalized approach to cancer care. Available as a single-site assay from Tempus Labs in Chicago, the xT CDx embodies a leap forward in how cancer biomarker screening informs and enhances clinical decisions.

Tempus Inc.
CPU, Embedded Memories
View Details

DPYD Test

The DPYD Test is an advanced genetic screening tool designed to evaluate risk levels associated with toxicity from 5-FU and capecitabine treatments in cancer patients. Through the assessment of the DPYD gene, which encodes the enzyme dihydropyrimidine dehydrogenase, the test identifies patients at heightened risk for serious side effects from these chemotherapies. This is especially critical for addressing adverse effects in colorectal, breast, pancreatic, and other gastrointestinal cancers.\n\nDesigned to support clinical decision-making, the DPYD Test provides a comprehensive genetic profile that includes five specific single nucleotide variants (SNVs) within the DPYD gene. These genetic insights help oncologists to personalize chemotherapy regimens, minimizing the risk of toxicity by identifying patients who may need adjusted dosages or alternative treatments.\n\nThe DPYD Test is available as an add-on to existing Tempus diagnostic tools, amplifying its utility in a clinical setting. By offering expanded toxicity risk assessment without the need for additional tissue samples, it emphasizes convenience and accuracy, ensuring safer and more effective chemotherapy management for patients with cancer.

Tempus Inc.
CPU, Embedded Memories
View Details

Latest News About Tempus Inc.

Intel's Strategic Foundry Partnerships: A New Era of Collaboration

Intel expands its foundry ecosystem with alliances with TSMC, UMC, and Taiwanese tech partners, marking a major transformation for the firm's production strategy. Read more

Sign up to Silicon Hub to buy and sell semiconductor IP

Sign Up for Silicon Hub

Join the world's most advanced semiconductor IP marketplace!

It's free, and you'll get all the tools you need to discover IP, meet vendors and manage your IP workflow!

No credit card or payment details required.

Sign up to Silicon Hub to buy and sell semiconductor IP

Welcome to Silicon Hub

Join the world's most advanced AI-powered semiconductor IP marketplace!

It's free, and you'll get all the tools you need to advertise and discover semiconductor IP, keep up-to-date with the latest semiconductor news and more!

Plus we'll send you our free weekly report on the semiconductor industry and the latest IP launches!

Switch to a Silicon Hub buyer account to buy semiconductor IP

Switch to a Buyer Account

To evaluate IP you need to be logged into a buyer profile. Select a profile below, or create a new buyer profile for your company.

Add new company

Switch to a Silicon Hub buyer account to buy semiconductor IP

Create a Buyer Account

To evaluate IP you need to be logged into a buyer profile. It's free to create a buyer profile for your company.

Review added

Claim Your Business

Please enter your work email and we'll send you a link to claim your business.

Review added

Claim Email Sent

Please check your email for a link you can use to claim this business profile.

Chatting with Volt